Sign in

CIK 0000818686

  • Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 39148213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,242,786
in 10 filings, $10.6M under 10b5-1 plans

Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-02-11 Sabag Mark See "Remarks" below Grant or award · Restricted Share Units +19,040 19,040
2020-02-11 Fridriksdottir Hafrun Executive VP, Global R&D Grant or award · Restricted Share Units +17,850 17,850
2020-02-11 Drape Eric Executive VP Global Operations Grant or award · Restricted Share Units +13,090 13,090
2020-02-10 Stark David Matthew Exec. VP Chief Legal Officer Sale −12,538 $12.24 $153K 2,974.39
2020-02-10 O'Grady Brendan P. EVP, North America Commercial Sale −4,799 $12.27 $59K 13,456.49
2020-02-10 Nazzi Gianfranco EVP, Growth Markets Commercial Sale −4,155 $12.24 $51K 18,464.36
2020-02-10 Fridriksdottir Hafrun Executive VP, Global R&D Sale −5,544 $12.27 $68K 33,329.51
2020-02-10 Drape Eric Executive VP Global Operations Sale −3,144 $12.24 $38K 20,618
2020-02-10 Dethlefs Sven EVP Global Marketing&Portfolio Sale −5,669 $12.27 $70K 18,060.7
2020-02-10 Daniell Richard Exec. VP, European Commercial Sale −6,199 $12.24 $76K 8,612
2020-02-09 Stark David Matthew Exec. VP Chief Legal Officer Option exercise +12,538 15,512.39
2020-02-09 Stark David Matthew Exec. VP Chief Legal Officer Option exercise · Restricted Share Units −12,538 25,076
2020-02-09 Schultz Kare President and CEO Option exercise +26,867 90,480
2020-02-09 Schultz Kare President and CEO Option exercise · Restricted Share Units −26,867 53,734
2020-02-09 Sabag Mark See "Remarks" below Option exercise +15,523 72,130.54
2020-02-09 Sabag Mark See "Remarks" below Option exercise · Restricted Share Units −15,523 31,046
2020-02-09 O'Grady Brendan P. EVP, North America Commercial Option exercise +16,120 18,255.49
2020-02-09 O'Grady Brendan P. EVP, North America Commercial Option exercise · Restricted Share Units −16,120 32,241
2020-02-09 Nazzi Gianfranco EVP, Growth Markets Commercial Option exercise +11,941 22,619.36
2020-02-09 Nazzi Gianfranco EVP, Growth Markets Commercial Option exercise · Restricted Share Units −11,941 23,882

Page 60 of 76 · 1,517 trades